ANSYS FRANCE SAS

Their core work

ANSYS France is the French subsidiary of ANSYS Inc., one of the world's leading providers of engineering simulation software. They supply multi-physics simulation tools — including computational fluid dynamics (CFD), finite element modelling (FEM), and fluid-structure interaction (FSI) — to research consortia tackling complex engineering and biomedical problems. In H2020 projects, they contribute simulation expertise and software platforms that enable partners to build predictive digital models, from patient-specific cardiovascular simulations to cyber-physical system architectures. Their role is typically that of a technology provider embedding industrial-grade simulation capability into collaborative research.

What they specialise in

How they've shifted over time

ANSYS France's early H2020 involvement (2015–2018) centred on foundational engineering simulation — wind energy harvesting (AEOLUS4FUTURE), cardiovascular modelling (VPH-CaSE, EurValve), and gas turbine combustion (MAGISTER), all leveraging their core CFD/FEM capabilities in traditional engineering domains. From 2018 onward, their focus shifted decisively toward medical digital twins and predictive healthcare (PRIMAGE for cancer, MeDiTATe for aneurysms), alongside industrial cyber-physical systems (CPS4EU). Their most recent engagements as third parties in materials-focused projects (nanoMECommons, iclimabuilt) suggest a broadening into advanced materials simulation.

ANSYS France is moving from general engineering simulation toward healthcare-specific digital twins and predictive modelling, making them an increasingly attractive partner for in-silico medicine and personalised treatment projects.

How they like to work

ANSYS France never coordinates — across all 10 projects they serve as participant or third party, which is consistent with a large software vendor contributing tools and expertise rather than leading research agendas. They operate in large consortia (160 unique partners across 23 countries), indicating a hub-style network where many different research groups integrate ANSYS simulation platforms into their work. This makes them a reliable, low-friction partner: they bring industrial-grade tools and technical support without competing for scientific leadership.

With 160 unique consortium partners across 23 countries, ANSYS France maintains one of the broadest collaboration networks among simulation providers in H2020. Their partnerships span universities, hospitals, research institutes, and industrial players across most of Western and Southern Europe.

What sets them apart

ANSYS France brings world-class commercial simulation software directly into EU research consortia — something few other partners can offer at this scale. Unlike academic simulation groups that build custom solvers, ANSYS provides production-ready, validated tools (CFD, FEM, CAE) that accelerate the path from research prototype to deployable solution. Their dual expertise in both traditional engineering and biomedical simulation makes them unusually versatile for cross-domain projects.

Highlights from their portfolio

• PRIMAGE
  Largest single EC contribution (EUR 810,874) — predictive in-silico analytics for childhood cancer diagnosis combining imaging biomarkers with computational modelling.
• MeDiTATe
  Medical digital twin for aneurysm treatment integrating CFD, FEM, FSI, HPC, GPU computing, and augmented reality — showcases the full depth of ANSYS simulation capabilities.
• CPS4EU
  Strategic European initiative on cyber-physical systems spanning automotive, aerospace, energy, and manufacturing automation — positions ANSYS in the Industry 4.0 ecosystem.